Agios Strengthens Team with Key Appointments and Promotion Read more about Agios Strengthens Team with Key Appointments and Promotion
Agios Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference Read more about Agios Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
BIO Welcomes David Schenkein, M.D., to the Emerging Companies Section Governing Board Read more about BIO Welcomes David Schenkein, M.D., to the Emerging Companies Section Governing Board
Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer Read more about Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer
Agios Pharmaceuticals, Inc. and The University of Pennsylvania Announce New Collaboration Read more about Agios Pharmaceuticals, Inc. and The University of Pennsylvania Announce New Collaboration
The University of Pennsylvania, The Abramson Family Cancer Research Institute at the Abramson Cancer Center of UPenn, Craig Thompson, M.D., Agios Pharmaceuticals and Celgene Corporation Announce Resolution of Lawsuits Read more about The University of Pennsylvania, The Abramson Family Cancer Research Institute at the Abramson Cancer Center of UPenn, Craig Thompson, M.D., Agios Pharmaceuticals and Celgene Corporation Announce Resolution of Lawsuits
Agios Pharmaceuticals to Present at the UBS Global Life Sciences Conference Read more about Agios Pharmaceuticals to Present at the UBS Global Life Sciences Conference
New Publications from Agios Scientists and Collaborators Reveal Unexpected Regulation of Metabolic Pathways in Cancer Read more about New Publications from Agios Scientists and Collaborators Reveal Unexpected Regulation of Metabolic Pathways in Cancer
Agios Publication Identifies First PotentInhibitors of Mutant IDH1 that Lower Tumor Oncometabolite Read more about Agios Publication Identifies First PotentInhibitors of Mutant IDH1 that Lower Tumor Oncometabolite
Agios Pharmaceuticals, Inc. to Present at 31st Annual J.P. Morgan Healthcare Conference Read more about Agios Pharmaceuticals, Inc. to Present at 31st Annual J.P. Morgan Healthcare Conference